PETVW (PetVivo Holdings) Research & Development: $1.28 Mil (TTM As of Dec. 2025)


PETVW PetVivo Holdings Inc PETVW
35 GF Score
Price $0.01
! 6 Warning Signs
View Full Analysis

What is PetVivo Holdings Research & Development?

PetVivo Holdings PETVW 35 Research & Development is $1.28 Mil as of Dec. 2025. GuruFocus rates PETVW with a GF Score™ of 35/100. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PetVivo Holdings's Research & Development for the three months ended in Dec. 2025 was $0.32 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $1.28 Mil.

PetVivo Holdings  (OTCPK:PETVW) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PetVivo Holdings Research & Development Related Terms

PetVivo Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for PetVivo Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PetVivo Holdings Research & Development Chart

PetVivo Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.48 1.00 1.40 1.58

PetVivo Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.36 0.34 0.26 0.32
PETVW
35GF Score
PetVivo Holdings Inc PETVW
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PetVivo Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1.28 Mil mean?
PetVivo Holdings (PETVW) has a Research & Development of $1.28 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on PetVivo Holdings and its competitors.
Is PetVivo Holdings' Research & Development too high?
PetVivo Holdings' current Research & Development is $1.28 Mil. Overall, PetVivo Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PetVivo Holdings' Research & Development compare to MODD and NMTC?
PetVivo Holdings' Research & Development of $1.28 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PetVivo Holdings and its competitors. PetVivo Holdings's current Research & Development is $1.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetVivo Holdings stock overvalued right now?
PetVivo Holdings (PETVW) has a current Research & Development of $1.28 Mil. The current Research & Development is $1.28 Mil. PetVivo Holdings' overall GF Score™ is 35/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PetVivo Holdings (PETVW), the current Research & Development is $1.28 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PetVivo Holdings Business Description

Other Exchanges PETV:USA
Address 5151 Edina Industrial Boulevard, Suite 575, Edina, MN, USA, 55439
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
35GF Score

Get the complete analysis for PETVW

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price